| 1 | Emerging coronaviruses: Genome structure, replication, and pathogenesis | Journal of Medical Virology | 2020 | 2,326 |
| 2 | Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle | Journal of Medical Virology | 2020 | 2,261 |
| 3 | The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients | Journal of Medical Virology | 2020 | 1,669 |
| 4 | Coronavirus infections and immune responses | Journal of Medical Virology | 2020 | 1,320 |
| 5 | Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis | Journal of Medical Virology | 2020 | 1,262 |
| 6 | The cytokine storm and COVID‐19 | Journal of Medical Virology | 2021 | 1,112 |
| 7 | Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures | Journal of Medical Virology | 2020 | 1,050 |
| 8 | COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis | Journal of Medical Virology | 2020 | 1,021 |
| 9 | Norwalk virus: How infectious is it? | Journal of Medical Virology | 2008 | 992 |
| 10 | Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation | Journal of Medical Virology | 2021 | 984 |
| 11 | Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China | Journal of Medical Virology | 2020 | 977 |
| 12 | Tocilizumab treatment in COVID‐19: A single center experience | Journal of Medical Virology | 2020 | 965 |
| 13 | Potential interventions for novel coronavirus in China: A systematic review | Journal of Medical Virology | 2020 | 911 |
| 14 | Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection | Journal of Medical Virology | 2020 | 839 |
| 15 | Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 | Journal of Medical Virology | 2020 | 744 |
| 16 | Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) | Journal of Medical Virology | 2020 | 744 |
| 17 | Clinical features and treatment of COVID‐19 patients in northeast Chongqing | Journal of Medical Virology | 2020 | 716 |
| 18 | Understanding of COVID‐19 based on current evidence | Journal of Medical Virology | 2020 | 716 |
| 19 | Rapid and quantitative detection of human adenovirus DNA by real‐time PCR | Journal of Medical Virology | 2003 | 684 |
| 20 | Cross‐species transmission of the newly identified coronavirus 2019‐nCoV | Journal of Medical Virology | 2020 | 649 |
| 21 | The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients | Journal of Medical Virology | 2020 | 625 |
| 22 | Coronavirus disease 2019: What we know? | Journal of Medical Virology | 2020 | 609 |
| 23 | Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines | Journal of Medical Virology | 2022 | 600 |
| 24 | An interferon-?-related cytokine storm in SARS patients | Journal of Medical Virology | 2005 | 576 |
| 25 | Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors | Journal of Medical Virology | 2000 | 561 |
| 26 | Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 | Journal of Medical Virology | 2020 | 534 |
| 27 | The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis | Journal of Medical Virology | 2020 | 523 |
| 28 | Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 | Journal of Medical Virology | 2020 | 500 |
| 29 | Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40 | Journal of Medical Virology | 2003 | 498 |
| 30 | Sequence and genomic organization of GBV-C: A novel member of the flaviviridae associated with human non-A-E hepatitis | Journal of Medical Virology | 1996 | 482 |
| 31 | Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes | Journal of Medical Virology | 2021 | 472 |
| 32 | Antiviral effect of flavonoids on human viruses | Journal of Medical Virology | 1985 | 452 |
| 33 | The 2019‐new coronavirus epidemic: Evidence for virus evolution | Journal of Medical Virology | 2020 | 449 |
| 34 | Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis | Journal of Medical Virology | 2020 | 446 |
| 35 | Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis | Journal of Medical Virology | 2020 | 444 |
| 36 | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV | Journal of Medical Virology | 2020 | 430 |
| 37 | Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein | Journal of Medical Virology | 2022 | 423 |
| 38 | Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis | Journal of Medical Virology | 2020 | 421 |
| 39 | Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis | Journal of Medical Virology | 2020 | 420 |
| 40 | Transmission dynamics of the COVID‐19 outbreak and effectiveness of government interventions: A data‐driven analysis | Journal of Medical Virology | 2020 | 399 |
| 41 | False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence | Journal of Medical Virology | 2020 | 396 |
| 42 | Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19 | Journal of Medical Virology | 2020 | 395 |
| 43 | C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early | Journal of Medical Virology | 2020 | 393 |
| 44 | Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19 | Journal of Medical Virology | 2020 | 389 |
| 45 | Pathology of fatal human infection associated with avian influenza A H5N1 virus | Journal of Medical Virology | 2001 | 378 |
| 46 | Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis | Journal of Medical Virology | 2022 | 378 |
| 47 | Recent advances in the detection of respiratory virus infection in humans | Journal of Medical Virology | 2020 | 373 |
| 48 | In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs | Journal of Medical Virology | 2020 | 366 |
| 49 | Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals | Journal of Medical Virology | 2000 | 361 |
| 50 | Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis | Journal of Medical Virology | 2020 | 358 |